← All trials
NCT04358809
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2020
- Primary completion
- Feb 28, 2021
- Completion date
- Apr 30, 2021
- First posted
- Apr 24, 2020
- Last posted
- Apr 24, 2020
- Enrollment
- 480
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cadila HealthcareLead sponsor
- Council of Scientific and Industrial Research, IndiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.